1246815-57-5
1246815-57-5
Chemical Structure
Perazine-d8
- CAS No.: 1246815-57-5
- Formula:C20H17D8N3S
- Molecular Weight:347.55
IUPAC Name: 10-(3-(4-methylpiperazin-1-yl-2,2,3,3,5,5,6,6-d8)propyl)-10H-phenothiazine
InChIKey: WEYVCQFUGFRXOM-DBVREXLBSA-N
SMILES: CN(C([2H])([2H])C1([2H])[2H])C([2H])([2H])C([2H])([2H])N1CCCN2C3=CC=CC=C3SC4=CC=CC=C42
Biological Activity: Perazine-d8 is a deuterated form of Perazine. Perazine is a potent and orally active antidepressant agent. Perazine has the potential for the research of acute schizophrenics[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Perazine-d8 | Perazine-d8 is a deuterated form of Perazine. Perazine is a potent and orally active antidepressant agent. Perazine has the potential for the research of acute schizophrenics. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Wójcikowski J, et al. Distribution interactions between perazine and antidepressant drugs. In vivo studies. Pol J Pharmacol. 2000 Nov-Dec;52(6):449-57. [Content Brief]
- [2]. Breyer-Pfaff U, et al. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Pharmacokinetic data. Pharmacopsychiatria. 1983 Sep;16(5):160-5. [Content Brief]
